Garo Armen Increases Stake in AGEN with Recent Purchase

Garo Armen, the Chairman, Chief Executive Officer, and Principal Financial Officer of AGEN, recently bought 4,925 shares of the company at $3.30 each. This transaction took place on June 12, 2026, amounting to a total value of $16,252.50. Armen's purchase is not part of a pre-planned trading program, indicating a personal decision to invest further in the company.

Insider Buying and Selling at AGEN

Garo Armen has been actively buying shares of AGEN over the past few months. Prior to this latest acquisition, he purchased 4,644 shares on May 29 at $3.50 each, 4,540 shares on May 15 at $3.58 each, and 4,233 shares on May 1 at $3.84 each. These purchases highlight his ongoing confidence in the company's future prospects. Additionally, Timothy Wright and Thomas Harrison also made significant purchases on April 24, buying 105,000 and 122,500 shares respectively.

Other Institutional Activity in AGEN

Institutional investors have also shown interest in AGEN. Vanguard Capital Management LLC added 1,440,232 shares, bringing its total to 1,440,232 shares, valued at approximately $4.81 million. Vanguard Portfolio Management LLC similarly increased its stake by 1,195,109 shares, now holding a total of 1,195,109 shares worth about $3.99 million. Marshall Wace, LLP significantly boosted its holdings by 541,403 shares to 688,203 shares, valued at around $2.30 million. Meanwhile, BlackRock, Inc. and Geode Capital Management, LLC slightly reduced their positions.

Analysts Set New Price Targets

On August 28, 2025, HC Wainwright & Co. reiterated its buy rating on AGEN with a price target of $23. Earlier, on June 4, 2025, the firm upgraded its rating to buy with a target of $25. Meanwhile, Baird has maintained a hold rating with a target of $6 as of June 4, 2025.

Bottom Line

Garo Armen's recent purchase of AGEN shares underscores his ongoing commitment to the company. Insider buying can signal confidence in the business's future, though it is not a guarantee of stock performance. Institutional investors have also been active, with several funds increasing their stakes. Analysts have varied views, with some firms setting optimistic price targets. Investors often track insider and institutional activity for insights into company performance.